Log In
Saturday 24th August 2019

Drug firms accused of overcharging

7th August 2015

CMA have accused Pfizer and Flynn Pharma of charging 'excessive and unfair' prices for anti-epilepsy drug.

Click on available sources in right hand menu to see the original article.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2019